84-1100-63 JARID1B (Jumonji/ARID Domain-containing Protein 1B) 20ul J7876-11

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • The methylation state of lysine residues in histone proteins is a major determinant for formation of active and inactive regions of the genome and is crucial for proper programming of the genome during development (1,2).
  • Jumonji C (JmjC) domain-containing proteins represent the largest class of potential histone demethylase proteins (3).
  • The JmjC domain can catalyze the demethylation of mono-, di-, and tri-methyl lysine residues via an oxidative reaction that requires iron and alpha-ketoglutarate (3).
  • Based on homology, both humans and mice contain at least 30 such proteins, which can be divided into 7 separate families (3).
  • The JARID (Jumonji/AT-rich interactive domain-containing protein) family contains four members: JARID1A (also RBP2 and RBBP2), JARID1B (also PLU-1), JARID1C (also SMCX) and JARID1D (also SMCY) (4).
  • In addition to the JmJC domain, these proteins contain JmJN, BRIGHT, C5HC2 zinc-finger, and PHD domains, the latter of which binds to methylated histone H3 (Lys9) (4).
  • All four JARID proteins demethylate di- and tri-methyl histone H3 Lys4; JARID1B also demethylates mono-methyl histone H3 Lys4 (5-7).
  • JARID1A is a critical RB-interacting protein and is required for Polycomb- Repressive Complex 2 (PRC2)-mediated transcriptional repression during ES cell differentiation (8).
  • A JARID1A-NUP98 gene fusion is associated with myeloid leukemia (9).
  • JARID1B, which interacts with many proteins including c-Myc and HDAC4, may play a role in cell fate decisions by blocking terminal differentiation (10-12).
  • JARID1B is over-expressed in many breast cancers and may act by repressing multiple tumor suppressor genes including BRCA1 and HOXA5 (13,14).
  • JARID1C has been found in a complex with HDAC1, HDAC2, G9a and REST, which binds to and represses REST target genes in non-neuronal cells (7).
  • JARID1C mutations are associated with X-linked mental retardation and epilepsy (15,16).
  • JARID1D is largely uncharacterized.
  • Applications:Suitable for use in Western Blot and Immunoprecipitation.
  • Other applications have not been tested.
  • Recommended Dilutions: Western Blot: 1:1000 Immunoprecipitation: 1:25 Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • For long-term storage, aliquot and store at -20°C.
  • Aliquots are stable for 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:20ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography.
  • Form:Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol
  • Specificity:Recognizes endogenous levels of human JARID1B protein. Does not cross-react with other JARID proteins, including JARID1A, JARID1C and JARID1D. Species Crossreactivity: monkey.
  • Isotype:IgG
  • Calc Applications Abbrev:IP WB
  • Calc Crossreactivity:Hu Mk
  • Immunogen:Synthetic peptide corresponding to the human JARID1B protein.
  • Shelf Life:1year
  • Swiss Prot Number:Q9UGL1
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1100-63
型番
J7876-11
入り数
1個
標準価格
108,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る